Digirad
Private Company
Total funding raised: $45M
Overview
Digirad is a long-established player in the diagnostic imaging sector, providing portable solid-state nuclear cameras and related service programs. Operating as part of Catalyst MedTech, the company's business model combines the sale of its proprietary imaging systems with a robust suite of service agreements, creating a recurring revenue stream. Its value proposition centers on reliability, portability, and minimizing patient downtime through flexible service and support. The company targets healthcare providers needing efficient nuclear imaging, particularly in cardiology.
Technology Platform
Solid-state detector technology (e.g., CZT) for digital nuclear imaging cameras, enabling portable, high-resolution SPECT imaging for cardiology and general nuclear medicine.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
Digirad competes in the niche solid-state nuclear camera segment against companies like Spectrum Dynamics Medical. It also faces broader competition from large multinational imaging conglomerates (GE HealthCare, Siemens Healthineers, Philips) that offer traditional gamma cameras and full-spectrum imaging solutions. Competition is based on technology, image quality, portability, service reliability, and total cost of ownership.